• LAST PRICE
    0.6600
  • TODAY'S CHANGE (%)
    Trending Up0.0900 (15.7895%)
  • Bid / Lots
    0.6600/ 53
  • Ask / Lots
    0.6799/ 2
  • Open / Previous Close
    0.5825 / 0.5700
  • Day Range
    Low 0.5825
    High 0.6900
  • 52 Week Range
    Low 0.2900
    High 1.8381
  • Volume
    37,582
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.57
TimeVolumeGLMD
09:32 ET11580.6499
09:33 ET1000.6499
09:37 ET5000.65
09:39 ET3000.65
09:50 ET1000.6897
09:51 ET16000.67
09:53 ET170210.6501
09:55 ET42000.65
10:08 ET13910.69
10:29 ET32200.66
10:36 ET4000.6822
10:44 ET1530.6799
10:47 ET1530.6601
11:30 ET15000.66995
11:34 ET34200.66
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGLMD
Galmed Pharmaceuticals Ltd
14.4M
-0.7x
---
United StatesTOVX
Theriva Biologics Inc
14.4M
-0.7x
---
United StatesMOBO
Avail Scientific Inc
14.3M
-2.5x
---
United StatesCEOS
CeCors Inc
14.6M
0.0x
---
United StatesGRAY
Graybug Vision Inc
14.1M
-0.4x
---
United StatesCLCS
Cell Source Inc
14.1M
-2.4x
---
As of 2023-01-31

Company Information

Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).

Contact Information

Headquarters
16 Ze'ev Tyomkin St. (4Th Fl.)TEL AVIV-YAFO, Israel 6578317
Phone
---
Fax
---

Executives

President, Chief Executive Officer, Director
Allen Baharaff
Chief Financial Officer
Doron Cohen
Chief Operating Officer, Data Protection Officer
Guy Nehemya
Chief Accounting Officer
Yohai Stenzler
Chief Scientific Officer
Liat Hayardeny

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$14.4M
Revenue (TTM)
$0.00
Shares Outstanding
25.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.13
EPS
$-0.90
Book Value
$1.22
P/E Ratio
-0.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.